Federal health regulators have prevented the release of multiple research studies that confirmed the safety profiles of commonly administered COVID-19 and shingles vaccines, according to a Tuesday report from the New York Times.
The research projects, which cost taxpayers millions of dollars to fund, involved scientists from the federal agency collaborating with data analysis companies to examine millions of medical records from patients.
According to the report, the research conclusions demonstrated that severe adverse reactions occurred extremely infrequently.
When contacted by Reuters for a statement, the Department of Health and Human Services, which supervises the FDA, had not provided an immediate response.
